Layout Table~~~~1508~1508~~

Nanomedicine 2006-2011~Published by Visiongain, June 2006

The purpose of this visiongain report is to examine the commercial prospects of nanotechnology in medicine – the fast-developing and increasingly lucrative field of nanomedicine. Nanotechnology has great potential to benefit - even revolutionise - the pharmaceutical, medical devices, diagnostics and imaging sectors. Visiongain predicts that nanomedicine will exhibit strong growth in all sectors from 2006-2011, leading to multi-billion dollar revenues. Key technology platforms such as nanocrystals, nanotubes, dendrimers, fullerenes, quantum dots and molecular scaffolding will drive that market expansion.

~Published by Visiongain, June 2006

The purpose of this visiongain report is to examine the commercial prospects of nanotechnology in medicine – the fast-developing and increasingly lucrative field of nanomedicine. Nanotechnology has great potential to benefit - even revolutionise - the pharmaceutical, medical devices, diagnostics and imaging sectors. Visiongain predicts that nanomedicine will exhibit strong growth in all sectors from 2006-2011, leading to multi-billion dollar revenues. Key technology platforms such as nanocrystals, nanotubes, dendrimers, fullerenes, quantum dots and molecular scaffolding will drive that market expansion.

Nanomedicine 2006-2011 examines the nanomedical sector critically through comprehensive primary and secondary research, including interviews with key figures in industry and academia, reports and policy documents, nanotechnology conference proceedings, business/industry news and consultation with bodies promoting nanotechnology. Visiongain applied techniques such as financial forecasting, SWOT analysis and qualitative projections to provide a comprehensive market report with detailed analyses and informed opinion.

In particular, this report concentrates on the following essential aspects of nanotechnology in the healthcare industry:

* Technologies that drive nanomedicine
* Key players in nanomedicine
* Revenue trends for nanotechnology in healthcare between 2006-2011
* Projected timetables for major developments up to 2020
* Drivers and opportunities in nanomedicine
* Restraints and threats in nanomedicine
* Funding and governmental policy in nanomedicine
* Venture capital in nanomedicine
* Regulation, safety and ethics of nanotechnology in medicine
* An assessment of relevant business models and issues
* A geographical breakdown of the world market for nanomedicine in 2011

Why you should buy this report

* To receive a comprehensive analysis of the prospects of the world nanomedical sector from 2006-2011
* To find out predicted revenues, growth rates and market shares for sectors within nanomedicine from 2006-2011
* To determine the forces that influence nanotechnology with medical applications:
* Competitive characteristics of the market
* Regulatory, funding and societal issues
Drivers and restraints
* Strengths, weaknesses, opportunities and threats
* To find out where nanotechnology in medicine is heading - both technologically and commercially - in the mid-to-long-term periods as well

Table of Contents ~Nanomedicine 2006-2011 (Single user License PDF)|926|Nanomedicine 2006-2011 (Department License PDF)|927|Nanomedicine 2006-2011 (Company wide license PDF)|928|~1508~3012~~

World Guide to Bionanotechnology Industry and its Progression~
Published by Bioseeker Group, October 2005

Nanotechnology, or the science of the small, holds enormous promise across all industries, not at least in life science. Since mid 90th there has been increasing intersection of two important scientific fields, nanotechnology and biotechnology, hence the name bionanotechnology. World Guide to Bionanotechnology Industry and its Progression covers the convergence of these two major high-tech fields. With their large base of academic research supported by extraordinary growth in national R&D budgets around the world is crating exciting new possibilities in a wide range of commercial applications such as:

~Published by Bioseeker Group, October 2005

Nanotechnology, or the science of the small, holds enormous promise across all industries, not at least in life science. Since mid 90th there has been increasing intersection of two important scientific fields, nanotechnology and biotechnology, hence the name bionanotechnology. World Guide to Bionanotechnology Industry and its Progression covers the convergence of these two major high-tech fields. With their large base of academic research supported by extraordinary growth in national R&D budgets around the world is crating exciting new possibilities in a wide range of commercial applications such as:

* NanoBiosensors
* NanoScale Micro- encapsulations
* NanoScale BioMechanics
* NanoTissue Engineering
* NanoScale Imaging
* NanoPharmaceuticals

Bionanotechnology will have a great impact on life science industries such as medical device, biotech equipment, diagnostic, and pharmaceuticals. The best way to learn about bionanotechnology in commercial applications is to study those how have adopted the technology. BioSeeker Research has in World Guide to Bionanotechnology Industry and its Progression outlined over 250 companies who have adopted bionanotechnology and gives you an insight to their technology platform, product development, collaborations and latest news.

The "World Guide to Bionanotechnology Industry and its Progression" product is based on BioSeeker's proprietary CD-ROM technology which includes smart database structure, find and sort options, internet and email interactivity. All companies are provided with links which connect you directly to the company webpage for further research. Both companies and pipeline projects can be further researched from inside the application by linking search queries directly to search engines like Google and PubMed. Found information on the CD-ROM may easily be shared with others over email or in print.

World Guide to Bionanotechnology Industry and its Progression is delivered to you as a CD-ROM product
Facts

Specific Information at Corporate Level

* More than 250 companies covered
* Nanotechnology platform descriptions
* Nano R&D pipeline projects
* Nano Partnerships
* News specific to nanotechnology development

Industry Segments with deployed Nanotechnology

* Biotechnology Equipment/Material
* CMO/CRO
* Diagnostics
* Enabling Technologies
* Medical Device
* Pharmaceutical/Therapeutics
* Service

Therapeutic Areas of Companies with Nanotechnology Platform

* Autoimmune/Inflammation
* Cancer
* Cardiovascular
* Dermatology
* Hematology
* Infectious diseases
* Metabolic diseases
* Neurological diseases
* Ophthalmic
* Pain
* Respiratory diseases

How May This Product Be of Use?

* Find competitors, collaborations partners, M&A candidates etc.
* Jump start competitive intelligence operations
* Excellent starting point for world wide benchmarking
* Compare portfolio and therapy focus with your peers
* Speed up pro-active in-/outlicensing strategy work
* Track companies over time using search engines
* Track drugs over time using search engines
* Show investors/board/management that you are right on top of industry development

All Information is Delivered to You as a CD-ROM

* Smart CD-ROM database
* Multiple search and sort functions included
* Company and drug data is linked to search engines like Google and PubMed
* Directs you directly to corporate web pages from inside the application
* Found information is easily shared with others over email or in print
* Easy to use and navigate by

System Requirements

* AMD-Athlon/Pentium II PC
* Windows 98/NT4/2000/ME/XP
* 8x-speed CD Rom drive
* SVGA 16 bit display. (32 bit recommended)
* 32 MB of available RAM (128 MB recommended)
* Internet access (to test web-enabled presentations)

~ World Guide to Bionanotechnology Industry and its Progression%3A Single User License|232|~1508~1547~~

The Impact of Nanotechnology in Drug Discovery~
Global Developments, Market Analysis and Future Prospects

Published By Nano Markets, April 2005

Nanotechnology has already enabled new formulations for drugs--for example, the FDA-approved Abraxane from American Pharmaceuticals, which has indications for the treatment of metastable breast cancers. Other drugs that are in the R&D pipeline or in regulatory approval stage are those developed by NanoHorizons for the treatment of skin disorders and infections. In the future, nanotechnology will enhance the drug discovery process, through miniaturization, automation, speed and reliability of assays. The research contained in this Report indicates that nano-enabled drug discovery can make important contributions to the pharmaceutical industry.~
Global Developments, Market Analysis and Future Prospects

Published by D&MD Publications, April 2005


Nanotechnology has already enabled new formulations for drugs--for example, the FDA-approved Abraxane from American Pharmaceuticals, which has indications for the treatment of metastable breast cancers. Other drugs that are in the R&D pipeline or in regulatory approval stage are those developed by NanoHorizons for the treatment of skin disorders and infections. In the future, nanotechnology will enhance the drug discovery process, through miniaturization, automation, speed and reliability of assays. The research contained in this Report indicates that nano-enabled drug discovery can make important contributions to the pharmaceutical industry
Report Overview

This report discusses how nano-enabled discovery and validation technologies can expand the hit rate for promising compounds in the pipeline, and expedite their progress through to market. It covers labs-on-a-chip/arrays, as well as nanoparticulate and self-assembled solutions and provides an in-depth analysis of all the drivers, restraints, challenges, regulatory issues and government funding policies that impact nano-enabled drug discovery. Also provided are profiles of the regulatory and funding environments for this kind of technology in 20 major countries. The Report provides eight-year forecasts that break out the market by key applications segments and product types.

Key Reasons to Buy

* Improve understanding of chemicals at the cellular/molecular level
* Improve identification and validation of target proteins and drugs
* Increase throughput
* Reduce the time required to identify new drugs
* Reduce the amount of precious reagents required to carry out screening of potential drugs
* Improve visualization of drug interactions

Target Audience

This report will be of vital interest to strategic planners, marketing managers and product development managers at all pharmaceutical, biotechnology, life science, test and measurement, specialty chemical, nanomaterials and biotechnology companies that may be interested in nanotechnology. This report may also benefit individuals and investors who track advances in the evolving nanotechnology market, including venture capitalists, healthcare equity analysts, academic researchers and scientific staff.

Table of Contents
~The Impact of Nanotechnology in Drug Discovery|238|~1508~1543~~